Ginsenoside rc attenuates dss-induced ulcerative colitis, intestinal in ammatory, and barrier function by activating the farnesoid x receptor

HIGHLIGHTS

• who: October and colleagues from the University of Kansas Medical Center, United States have published the research: Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal in ammatory, and barrier function by activating the farnesoid X receptor, in the Journal: (JOURNAL)
• what: The authors assess the anti-inflammation activity and intestinal damage repair ability of Rc on a dextran sulfate sodium (DSS)-induced IBD mice model. The authors aimed to explore the anti-inflammatory effects and the functional mechanism of Rc in IBD treatment. consistency + rectal bleeding) (Detel et_al, 2012). Consistently, the study showed symptoms such . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.